MacroGenics, Inc. MGNX
2.33 USD 0.00 (+0.00%)
At closeNov 3, 2026, 4:00 PM EST
2.33 0.00 0.00%
After hours · Nov 3, 4:00 PM ET
2.26 Day range 2.49
1.29 52-week range 5.08
- YTD
- +44.72%
- 1 year
- +47.47%
Analyst view
Price target (mean) 7.38 +216.5% upside
Now 2.33
- Target (low)
- 4.00
- Target (mean)
- 7.38
- Target (high)
- 14.00
Ratings (0m) 11 4 buy · 7 hold · 0 sell
- Strong buy1
- Buy3
- Hold7
- Sell0
- Strong sell0
Recommendation trend
- This month 11
- 1 month ago 11
- 2 months ago 11
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.55359 | -0.96 – -0.12 | -0.75 | +26.2% | 32.69M | +204.9% | 5 |
| Next quarter | -0.79333 | -1.10 – -0.58 | -0.84 | +5.6% | 14.06M | +54.4% | 3 |
| Current year | -1.38 | -1.79 – -0.95 | -2.58 | +46.5% | 159.93M | +172.2% | 5 |
| Next year | -2.50 | -3.01 – -1.40 | -1.38 | -80.8% | 77.97M | -51.2% | 5 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 7, 2024 | JMP Securities | Downgrade | Market Outperform | Market Perform |
| Nov 6, 2024 | HC Wainwright & Co. | Reiterated | Neutral | Neutral |
| Sep 18, 2024 | HC Wainwright & Co. | Reiterated | Neutral | Neutral |
| Aug 21, 2024 | HC Wainwright & Co. | Reiterated | Neutral | Neutral |
| Aug 15, 2024 | Citigroup | Maintained | Buy | Buy |
| Aug 7, 2024 | BMO Capital | Maintained | Market Perform | Market Perform |
| Aug 1, 2024 | BTIG | Downgrade | Buy | Neutral |
| Aug 1, 2024 | HC Wainwright & Co. | Reiterated | Neutral | Neutral |
| Jul 31, 2024 | JMP Securities | Maintained | Market Outperform | Market Outperform |
| Jul 31, 2024 | Barclays | Maintained | Overweight | Overweight |
| Jul 31, 2024 | Guggenheim | Downgrade | Buy | Neutral |
| Jul 31, 2024 | B. Riley Securities | Downgrade | Buy | Neutral |
| Jul 29, 2024 | Barclays | Maintained | Overweight | Overweight |
| May 24, 2024 | BTIG | Maintained | Buy | Buy |
| May 13, 2024 | HC Wainwright & Co. | Maintained | Neutral | Neutral |
| May 10, 2024 | Barclays | Maintained | Overweight | Overweight |
| May 10, 2024 | JMP Securities | Maintained | Market Outperform | Market Outperform |
| May 10, 2024 | BMO Capital | Downgrade | Outperform | Market Perform |
| May 10, 2024 | TD Cowen | Downgrade | Buy | Hold |
| May 10, 2024 | Stifel | Downgrade | Buy | Hold |
| Apr 9, 2024 | TD Cowen | Upgrade | Hold | Buy |
| Apr 4, 2024 | JMP Securities | Reiterated | — | Market Outperform |
| Mar 11, 2024 | Citigroup | Maintained | Buy | Buy |
| Mar 11, 2024 | JMP Securities | Maintained | Outperform | Outperform |
| Mar 11, 2024 | HC Wainwright & Co. | Maintained | Neutral | Neutral |
| Mar 8, 2024 | BMO Capital | Maintained | Outperform | Outperform |
| Mar 8, 2024 | Stifel | Maintained | Buy | Buy |
| Mar 8, 2024 | Barclays | Maintained | Overweight | Overweight |
| Mar 4, 2024 | BTIG | Maintained | Buy | Buy |
| Feb 29, 2024 | Barclays | Maintained | Overweight | Overweight |